1st Quarter - Report
DALRYMPLE & ASSOCIATES, LLC for EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)
Income
$46,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | Principal |
Homeland Security HOM
Anthrax vaccine and anthrax immune globulin research, acquisition and immunization funding, legislation, appropriations, and oversight.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | Principal |
Medical/Disease Research/Clinical Labs MED
Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | Principal |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.